ABSTRACT SUBMISSION IS CLOSED
Authors will be notified of the method of presentation, which will be decided by the Congress Programme Committee. Accepted abstracts will be published in a supplement to the European Journal of Neurology provided that the Congress Programme Committee considers them suitable for publication.
Abstract submitters will be informed of the status of their abstracts once the reviewing process is complete and prior to the early registration deadline of June 22, 2010.
ABSTRACTS OF INVITED SPEAKERS
Invited speakers will receive a special weblink for submission of abstracts, and are requested NOT to use the regular abstract submission form on the website.
METHOD OF SUBMISSION
Abstracts must be submitted via the internet. If you have no access to the internet, please contact the Secretariat.
GUIDELINES FOR SUBMISSION
1. The abstract should be as informative as possible:
- state specific object of study
- state method used if pertinent
- summarise results obtained
- state conclusions reached
2. Abstracts should be structured.
3. Standard abbreviations may be used.
4. Inclusion in the Scientific Programme and Abstract Volume is dependent on payment of registration fees.
5. Facilities for computerized projection will be available for all congress sessions (teaching courses, main
topics, short communications, focused workshops, and special sessions). Video projection (European
VHS/PAL system, low band) and overhead projection will be provided only if ordered by July 20, 2010.
6. Abstracts should be submitted in good English.
7. Abstract length should not exceed 250 words.
8. Abstracts that were published at previous events/in other publicatons, i.e. encore abstracts, cannot be
accepted.
9. Important note: A maximum of 3 abstracts per presenting author may be submitted.
Abstracts should be submitted using the internet site of the congress.
Faxed abstracts are not acceptable. |
Click here to see the Abstracts Topics.
LATE BREAKING NEWS
Abstract submission is closed.
If data are not yet available at submission deadline, authors should present background and design of the study in their abstract and confirm that the results and conclusions of their investigations will be ready for presentation at the 14th EFNS Congress. Please send your confirmation about this in writing by e-mail, fax or regular mail when submitting your abstract to:
14th EFNS Congress
1-3 rue de Chantepoulet, PO Box 1726
CH-1211 Geneva 1, Switzerland
Tel: +41 22 908 04 88, Fax: +41 22 906 91 40
E-mail: efns2010@kenes.com
Website: www.efns.org/efns2010
As in the nature of the wording, late breaking abstracts are NOT regular abstracts, but important contributions that cannot wait to be presented at the next EFNS congress. Late abstract submissions will not be accepted.
No case reports will be accepted. Only a limited number of high-standard abstracts can be retained for one oral session on the last day of the congress. These abstracts must be exclusively related to results of new treatments of neurological disorders, which have not been presented at any other national or international congress. Interesting abstracts, not retained for the oral session, can only be presented as poster without publication.
ONGOING CLINICAL TRIALS
A special poster session on ongoing clinical trials might be held provided that a sufficient number of good abstracts meeting this particular format and its criteria will be received and selected. If you wish to present your study at this session, please add “ongoing clinical trial” after the title. This special poster session is mainly aiming at raising awareness about new studies and to allow possible new centres to be involved.